Phase II study of the PI3K inhibitor pilaralisib...

Gynecologic Oncology 2015 / 02 Vol. 136; Iss. 2

Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma

Matulonis, Ursula, Vergote, Ignace, Backes, Floor, Martin, Lainie P., McMeekin, Scott, Birrer, Michael, Campana, Frank, Xu, Yi, Egile, Coumaran, Ghamande, Sharad
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
136
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.12.019
Date:
February, 2015
File:
PDF, 523 KB
english, 2015
Conversion to is in progress
Conversion to is failed